Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $9.36 USD
Change Today -0.07 / -0.74%
Volume 70.2K
STAA On Other Exchanges
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

staar surgical co (STAA) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/7/14 - $14.17
52 Week Low
01/27/15 - $4.84
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for STAAR SURGICAL CO (STAA)

Related News

No related news articles were found.

staar surgical co (STAA) Related Businessweek News

No Related Businessweek News Found

staar surgical co (STAA) Details

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye, and delivery systems to deliver lenses into the eye. The company offers implantable collamer lenses (ICL) comprising Visian ICL to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also provides invasive intraocular lenses (IOL) that include aspheric IOLs that produce a clearer image than traditional spherical lenses; nanoFLEX IOL, a single piece collamer aspheric optic; Toric IOL for cataract patients to treat pre-existing astigmatism; and Preloaded Injector, a silicone or acrylic IOL preloaded into a single-use disposable injector. In addition, the company sells surgical products, and other related instruments and devices; and manufactures AquaFlow device for the treatment of glaucoma. It markets its products to health care providers, including surgical centers, hospitals, managed care providers, health maintenance organizations, group purchasing organizations, and government facilities. The company offers its products primarily under the STAAR, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, Epiphany, and AquaFlow names. It sells products directly through its sales representatives in the United States, Canada, Japan, and Spain, as well as through independent distributors in approximately 60 countries worldwide. STAAR Surgical Company was founded in 1982 and is headquartered in Monrovia, California.

300 Employees
Last Reported Date: 03/13/15
Founded in 1982

staar surgical co (STAA) Top Compensated Officers

Chief Financial Officer and Vice President
Total Annual Compensation: $303.8K
Chief Accounting Officer and Vice President
Total Annual Compensation: $334.4K
Vice President of Business Development, Corpo...
Total Annual Compensation: $336.2K
Vice President of Global Marketing
Total Annual Compensation: $266.2K
Compensation as of Fiscal Year 2014.

staar surgical co (STAA) Key Developments

STAAR Surgical Company Announces the Resignation of Robin Hughes as Vice President, Global Research and Development, and Clinical, with Effect from May 1, 2015

On April 30, 2015, Robin Hughes, a named executive officer of STAAR Surgical Company, informed the Company of his decision to resign effective May 1, 2015. Mr. Hughes became an executive officer of the Company in 2007 and is its Vice President, Global Research and Development, and Clinical. Mr. Hughes will receive compensation consistent with the Executive Severance Agreement entered into with the Company in 2011, the terms of which were previously disclosed by the Company.

STAAR Surgical Company Announces Unaudited Consolidated Earnings Results for the First Quarter Ended April 3, 2015

STAAR Surgical Company announced unaudited consolidated earnings results for the first quarter ended April 3, 2015. For the quarter, the company reported net sales were $18.9 million for the first quarter of 2015, a decrease of 7% compared to $20.2 million reported in the prior year. The net loss was $2.3 million or $0.06 per diluted share, compared with a net loss of $1.4 million or $0.04 per diluted share, for the prior year period. Adjusted net income was $1.1 million or $0.03 per diluted share, compared with adjusted net income of $1.6 million or $0.04 per diluted share, for the prior year period. Operating loss was $1,510,000 against $1,342,000 a year ago. Loss before provision for income taxes was $2,368,000 against $1,140,000 a year ago. Net cash used in operating activities was $2,209,000 against $2,594,000 a year ago. Acquisition of property and equipment was $328,000 against $1,414,000 a year ago.

STAAR Surgical Company Appoints J. Steven Roush to its Board

STAAR Surgical Company announced that its Board of Directors has appointed J. Steven Roush, CPA to the company's Board. Mr. Roush brings an important combination of financial regulatory and reporting agencies expertise, largely gained over a 39 year tenure as a Partner at PricewaterhouseCoopers, prior to his retirement in 2007. He is currently a member of the Board and Chairman of the Audit Committee for Summit Healthcare REIT. Currently, Mr. Roush is also a Board Member of Air Touch Communications and WE Hall Company.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STAA:US $9.36 USD -0.07

STAA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bovie Medical Corp $2.66 USD -0.05
Ellex Medical Lasers Ltd A$0.30 AUD 0.00
Glaukos Corp $28.09 USD +0.09
IRIDEX Corp $8.22 USD +0.26
Vascular Solutions Inc $34.32 USD -0.47
View Industry Companies

Industry Analysis


Industry Average

Valuation STAA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.9x
Price/Book 10.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STAAR SURGICAL CO, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at